ロード中...
NMNAT3 is protective against the effects of neonatal cerebral hypoxia‐ischemia
OBJECTIVE: To determine whether the NAD+ biosynthetic protein, nicotinamide mononucleotide adenylyltransferase‐3 (NMNAT3), is a neuroprotective inducible enzyme capable of decreasing cerebral injury after neonatal hypoxia‐ischemia (H‐I) and reducing glutamate receptor‐mediated excitotoxic neurodegen...
保存先:
| 出版年: | Ann Clin Transl Neurol |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley and Sons Inc.
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5634348/ https://ncbi.nlm.nih.gov/pubmed/29046881 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/acn3.450 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|